Reviva Pharmaceuticals Holdings, Inc. Derivative Liability, Noncurrent
Reviva Pharmaceuticals Holdings, Inc. (RVPH) had Derivative Liability, Noncurrent of $0 as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2026-03-30
- 2025-12-31: Derivative Liability, Noncurrent $0.00.
- 2025-09-30: Derivative Liability, Noncurrent $44.51K.
- 2025-06-30: Derivative Liability, Noncurrent $16.69K.
- 2025-03-31: Derivative Liability, Noncurrent $27.82K.
| Period end | Derivative Liability, Noncurrent |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-30 |
| 2025-09-30 | $44.51K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $16.69K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $27.82K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $89.01K 10-K · filed 2026-03-30 |
| 2024-09-30 | $77.88K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $150.21K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $350.48K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $806.65K 10-K · filed 2025-04-03 |
| 2023-09-30 | $873.41K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $1.01M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $556.31K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $567.44K 10-K · filed 2024-04-15 |
| 2022-09-30 | $105.70K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $105.70K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $283.72K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $372.73K 10-K · filed 2023-03-30 |
| 2021-09-30 | $650.89K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $851.16K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $1.04M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $1.96M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |